Weekly Digest – October 2025 Weekly Digest – October 2025 27 October 2025: GSK acquires exclusive rights from Syndivia for antibody-drug conjugate (ADC) in prostate cancer GSK secured exclusive global rights from Syndivia to develop and commercialize a preclinical antibody-drug […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id